0
Editorials |

Reducing COPD ReadmissionsReducing COPD Readmissions: Great Promise but Big Problems

David M. Mannino, MD, FCCP; Byron Thomashow, MD, FCCP
Author and Funding Information

From the Department of Preventive Medicine and Environmental Health (Dr Mannino), University of Kentucky College of Public Health; and Department of Pulmonary and Critical Care Medicine (Dr Thomashow), Columbia University Medical Center, Columbia University.

CORRESPONDENCE TO: David M. Mannino, MD, FCCP, Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, 111 Washington Ave, Lexington, KY 40536; e-mail: dmannino@uky.edu


FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following conflicts of interest: Dr Mannino has served as a consultant for Boehringer Ingelheim GmbH; GlaxoSmithKline plc; AstraZeneca; Novartis AG; Merck Sharp & Dohme Corp; and Forest Laboratories, Inc and has received research grants from GlaxoSmithKline plc; Novartis AG; Boehringer Ingelheim GmbH; Forest Laboratories, Inc; and Pfizer Inc. He is also compensated by UpToDate, Inc, has served as an expert in tobacco-related cases, and is on the Board of the COPD Foundation. Dr Thomashow has served as a consultant for Boehringer Ingelheim GmbH and has served on advisory boards for GlaxoSmithKline plc; Novartis AG; Boehringer Ingelheim GmbH; Forest Laboratories, Inc; and Pfizer Inc. He is also the Chairman of the Board of the COPD Foundation.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.


Chest. 2015;147(5):1199-1201. doi:10.1378/chest.15-0380
Text Size: A A A
Published online

Extract

COPD is responsible for nearly 700,000 hospitalizations annually,1 and hospitalizations account for a large proportion of the annual direct medical costs of COPD.2 About 20% of patients hospitalized with COPD exacerbations are rehospitalized within 30 days of discharge,3 and these rehospitalizations are costly. One of the provisions in the Affordable Care Act targets reducing COPD rehospitalizations as a way to improve care and reduce costs.4 The Hospital Readmissions Reduction Program (HRRP) penalizes hospitals if admissions for COPD exacerbations exceed a higher than expected all-cause 30-day rehospitalization rate.4

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543